Health committee  I'll turn to my colleague, Mr. Allison, with respect to pan-Canadian data strategy. With respect to the national emergency strategic stockpile, the work that was done to create a pan-Canadian supply and demand model was very effective. That modelling served us well. That is work we will continue in our work with the provinces and territories.

Health committee  As I had mentioned, we worked with our federal colleagues to create a supply and demand model that looks at a number of factors in the information that's shared with us from the provinces and territories. We look at the epidemiology of COVID-19 and its progression, as well as ICU utilization.

Health committee  We've made significant progress in situating ourselves to be ready to respond to the current COVID situation. We now have an eight-week stockpiled supply of key personal protective commodities, including N95 respirators, surgical masks, gloves and face shields. We've been able to actively respond to 379 requests for assistance from the provinces and territories and other government departments to support them with necessary medical equipment and supplies.

Health committee  Working with the provinces and territories we were able to put in place a supply and demand model that helped us to establish what the key burn rates were during COVID-19. We worked with the provinces to determine the needs both for their stockpiles as well as for the Public Health Agency.

Health committee  Thank you, Mr. Chair. As I mentioned, GPHIN continues to be an important source of information, amounting to 20% of the feed-in to the World Health Organization's open-source data system. We are very interested in the international discussions on updates and potential changes to the international health regulations, and Public Health Agency officials will be participating in those discussions and certainly are actively interested to follow those.

Health committee  They would be sourced internationally. I don't have the specifics on each of the other contracts. They would come from a number of countries, including the U.S.

Health committee  Mr. Chair, certainly we'll undertake to provide all information possible within that seven-day time frame and follow up.

Health committee  Mr. Chair, the external independent panel announced by the Minister of Health in November 2020 released its final report in July 2021. A number of the key findings are, as has been mentioned, that the GPHIN did what it was designed to do, and it also confirmed that it had never been shut down.

Health committee  Mr. Chair, we'd be pleased to provide available information to the committee in writing.

Health committee  Mr. Chair, although the vaccine rollout is managed by the Public Health Agency, those officials are not here with us today to respond to the Office of the Auditor General's report, but we'd be pleased to follow up in writing with the committee on that question. Thank you.

Health committee  Mr. Chair, respectfully, it's outside of the purview of the the officials here today to speak to the vaccine rollout program—

Health committee  —but we would certainly undertake to provide appropriate information back to the committee in writing.

Health committee  Mr. Chair, with respect, it's outside of the purview of the officials here today to speak to the antiviral file. Again, we'd be happy to provide appropriate information to the committee in writing.

Health committee  Mr. Chair, the officials are here today prepared to answer questions with respect to the Auditor General's audit, so unfortunately we don't have an official today who could speak to that. We'd be happy to follow up with the committee in writing in response to those questions. Thank you.

Health committee  Mr. Chair, I'd be pleased to answer questions regarding the national emergency strategic stockpile and PPE.